|Bid||16.70 x 100|
|Ask||25.00 x 200|
|Day's Range||17.00 - 18.48|
|52 Week Range||3.43 - 25.80|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Almenoff brings more than 20 years of pharmaceutical executive experience from GlaxoSmithKline and from Furiex Pharmaceuticals, where as President and Chief Medical Officer, she oversaw the development ...
RALEIGH, N.C., March 07, 2018-- Innovate Biopharmaceuticals, Inc., a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, announced company ...
NEW YORK, NY / ACCESSWIRE / March 6, 2018 / Shares of both Innovate Biopharmaceuticals and Clearside BioMedical were heating up the biotech arena in the market on Monday. Innovate has now seen big gains ...
Innovate Biopharmaceuticals Inc (NASDAQ:INNT), a US$3.32M small-cap, operates in the healthcare industry, which continues to endure a more demanding healthcare agenda, and the global need for innovative, cost-effective medicines continuesRead More...
RALEIGH, N.C., Feb. 07, 2018-- Innovate Biopharmaceuticals, Inc. a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced company executives ...